Screening for hepatocellular carcinoma by Egyptian physicians

Table 9 Relation between health care setting and knowledge about screening modalities, educational resources and guidelines

	Health care setting				P value
	University		MOH
	n	%	n	%
Most important screening for HCC					0.000a
0.000a	3	3	0	0
Alpha fetoprotein	19	20	17	29
Ultrasound	70	74	27	46
CT	3	3	15	25
2nd most important screening for HCC					0.799
Physical examination	1	1	1	2
Alpha fetoprotein	47	49	24	40
Ultrasound	11	12	10	17
CT	35	37	23	39
Angiography	1	1	1	2
3rd most important screening for HCC					0.001a
Physical examination	2	2	3	5
Alpha fetoprotein	23	24	11	19
Ultrasound	10	11	7	12
CT	52	55	21	36
Angiography	7	8	4	7
Laparoscopy	1	1	13	22
Screening interval for high risk group					0.173
Every 3 mo	62	65	32	54
6 mo or more	33	35	27	46
HBV treatment reduces HCC incidence					0.011a
Yes	82	86	41	69
No	13	14	18	31
Guidelines in management of HCC					0.000a
Yes	73	77	17	29
No	22	23	42	71
HCV RNA/ALT are risk factors for HCC					0.139
Yes	48	51	37	63
No	47	49	22	37

^aP < 0.05 considered statistically significant. HCC: Hepatocellular carcinoma; HBV: Hepatitis B virus; HCV: Hepatitis C virus; MOH: Ministry of Health; CT: Computer tomography.